The Association considers, along the lines proposed by the European Medicines Agency, that the need to carry out comparative efficacy studies should be re-evaluated, at least for some biologicals, as they are dispensable.
The Association considers, along the lines proposed by the European Medicines Agency, that the need to carry out comparative efficacy studies should be re-evaluated, at least for some biologicals, as they are dispensable.
